Asked Oct 30, 10:46 AM EDT (morning session). Perplexity, Grok 4.7, Muse Spark 1.1, DeepSeek, Gemini 3 Pro, Claude Opus 5.5 and GPT-6 answered the same standard prompt independently. Window: from each model’s answer submission to the same US Eastern time on the next trading session (each SPY benchmark uses that model’s window). Benchmark: SPY.
Each pick scored on its return over the window in the direction the model called (a "down" call as a short), minus SPY’s return over the same window. In each chart SPY is on the left and the picks on the right, every candle drawn from zero to that asset's move; ✓ marks a pick that beat SPY over the window.
| Model | Correct | Hit rate | Return | SPY | Alpha vs SPY |
|---|---|---|---|---|---|
| Perplexity | 4/5 | 80.00% | 3.72% | 0.40% | 3.32% |
| Grok 4.7 | 4/5 | 80.00% | 5.12% | 0.40% | 4.72% |
| Muse Spark 1.1 | 4/5 | 80.00% | 4.78% | 0.31% | 4.47% |
| DeepSeek | 4/5 | 80.00% | 2.34% | 0.31% | 2.03% |
| Gemini 3 Pro | 3/5 | 60.00% | 1.42% | 0.22% | 1.20% |
| Claude Opus 5.5 | 3/5 | 60.00% | 3.25% | 0.22% | 3.03% |
| GPT-6 | 2/5 | 40.00% | 1.13% | 0.35% | 0.78% |
Perplexity
Scoring window: Oct 30, 10:48 AM EDT → Nov 2, 10:48 AM EST.
View full picks and reasoning
The one-day setup favors selective continuation in names with fresh, fundamental analyst support and an identifiable earnings or M&A catalyst, while avoiding names where a negative revision is already largely discounted. I favor DoorDash, GE Vernova, Rivian, and eBay for follow-through, and position Boston Scientific short because its guidance reset and cluster of downgrades create persistent fundamental pressure even after an initial sell-off.
- DASH — confidence 58%. Wedbush upgraded DoorDash to Outperform from Neutral and raised its target to $230 from $220, citing record Marketplace GOV, revenue, and the strategic logic of the announced $17B Instacart acquisition. The action was published on 2026-10-30; the source gives a date rather than a precise time, so published_at uses 00:00 US Eastern (-04:00).
Liquidity/size: market cap about $79.2B and price $182.78, both comfortably above thresholds. The $257M avg_dollar_volume_20d_usd shown here is a single-session proxy (latest reported volume of 1,409,160 shares times the latest price), not a verified 20-day average; actual 20-day turnover is likely higher.
Completed daily OHLCV: I could not verify five exact split-adjusted daily bars, return_5d_pct, high_20d, low_20d, or avg_volume_20d from the available source, so those figures are null. The history source is https://stockanalysis.com/stocks/dash/ and uses US Eastern regular sessions.
Price path: before the upgrade, DASH had already gapped higher on the Instacart announcement; the verified live quote was $182.78 at 2026-10-30T10:18:00-04:00, up 2.11% on the session, with a partial-session open of $180.16, high of $185.68, low of $175.29, and cumulative volume of 1,409,160 shares. The observed move from the prior close of $179.00 to the live quote is about +2.11%; a verified pre-action quote is not available, so the event-specific reaction is null.
Thesis: the upgrade reinforces a fundamental consolidation thesis rather than merely sentiment, and the stock is holding most of its post-deal gain. I expect additional upside over the remaining window as the acquisition and record operating results remain the focus. Strongest counter-evidence: several other firms cut targets after earnings, and the day's low of $175.29 shows active selling. Invalidation: a sustained break below the partial-session low near $175.29, or renewed skepticism about acquisition financing/regulatory risk, would negate the upside case.
Wedbush (Ygal Arounian) upgraded to Outperform, target $230 (from $220) on 2026-10-30 — source
Return: 4.22%; alpha: 3.82%. - GEV — confidence 52%. HSBC upgraded GE Vernova to Buy from Hold and raised its price target to $1,100 from $1,040 on 2026-10-30. The source provides only the date, so published_at is set to 00:00 US Eastern (-04:00).
Liquidity/size: market cap about $233.75B and reference price $887.85 clear the thresholds. The $3.09B avg_dollar_volume_20d_usd is a latest-session proxy (3,483,943 shares times $887.85), not a verified 20-day average.
Completed daily OHLCV: exact five-session OHLC, return_5d_pct, 20-session high/low, and 20-day average volume could not be verified from the available page and are null. History source: https://stockanalysis.com/stocks/gev/, US Eastern regular sessions.
Price path: GEV reported Q3 revenue of $12.64B versus $12B consensus, orders up 96%, raised 2026 guidance, and announced a $9B Trench acquisition. The latest completed close was $887.85 on 2026-10-29, up 1.12%, but the after-hours quote was $863.14, down 2.78%, indicating that the initial earnings enthusiasm faced late selling. The verified pre-event price is not available, so event reaction is null.
Thesis: the HSBC upgrade is supported by a genuine improvement in orders, guidance, and free-cash-flow expectations, not just a sentiment shift. I expect a modest upward move as investors weigh the raised outlook against the already elevated valuation. Strongest counter-evidence: the negative after-hours quote and multiple target reductions from other banks after earnings. Invalidation: a close below the October 29 after-hours level near $863 would suggest the fundamental upgrade is being overwhelmed by valuation or deal-related concerns.
HSBC upgraded to Buy, target $1100 (from $1040) on 2026-10-30 — source
Return: 3.74%; alpha: 3.34%. - RIVN — confidence 60%. Jefferies upgraded Rivian to Buy from Hold with a $17 target on 2026-10-30, following Q3 results. The source gives only the date, so published_at is 00:00 US Eastern (-04:00).
Liquidity/size: market cap about $16.58B and reference price $11.45 meet the thresholds. The $493M avg_dollar_volume_20d_usd is a latest-session proxy (43,102,363 shares times $11.45), not a verified 20-day average.
Completed daily OHLCV: five exact daily bars, return_5d_pct, 20-session high/low, and 20-day average volume were not verifiable from the available page and are null. History source: https://stockanalysis.com/stocks/rivn/, US Eastern regular sessions.
Price path: Rivian beat Q3 expectations, reported record production and deliveries, raised 2026 delivery guidance, and pointed to improving R2 demand and a potential $250M Uber funding milestone. The latest completed close was $11.45 on 2026-10-29, down 1.89%, but the after-hours quote was $12.10, up 5.68%, showing a positive immediate earnings/upgrade reaction. A verified pre-event quote is not available, so event-specific reaction is null.
Thesis: this is a fundamentals-driven upgrade after an earnings beat and guidance increase, giving the call more durability than a valuation-only rating change. I expect continuation over the one-day window as the after-hours gain is digested. Strongest counter-evidence: the stock closed lower into the release and remains near its 52-week low of $11.38, so failure to hold the after-hours gain would signal exhaustion. Invalidation: a move back below $11.38 would invalidate the continuation thesis.
Jefferies upgraded to Buy, target $17 on 2026-10-30 — source
Return: 11.53%; alpha: 11.12%. - EBAY — confidence 55%. Wells Fargo upgraded eBay to Equal Weight from Underweight and raised its target to $106 from $91 after Q3 results. The action was published on 2026-10-29; the source gives a date rather than a precise time, so published_at uses 00:00 US Eastern (-04:00).
Liquidity/size: market cap about $53.93B and reference price $121.19 clear the thresholds. The $898M avg_dollar_volume_20d_usd is a latest-session proxy (7,410,900 shares times $121.19), not a verified 20-day average.
Completed daily OHLCV: exact five-session OHLC, return_5d_pct, high_20d, low_20d, and avg_volume_20d could not be verified from the available page and are null. History source: https://stockanalysis.com/stocks/ebay/, US Eastern regular sessions.
Price path: eBay reported Q3 revenue of $3.2B versus $3.11B consensus, non-GAAP EPS of $1.51 versus $1.41 consensus, 13% organic GMV/revenue growth, and above-consensus Q4 and full-year guidance. The latest completed close was $121.19 on 2026-10-29, up 2.69%, with a day range of $118.37-$124.49; the after-hours quote was $122.59, up another 1.16%. A verified pre-action quote is not available, so the action-specific reaction is null.
Thesis: the upgrade removes a bearish rating while the broader analyst community raised targets, indicating a real change in expectations for growth and estimates rather than an isolated sentiment call. I expect modest further upside as the strong results and guidance continue to be priced in. Strongest counter-evidence: the stock is near its 52-week high of $124.59 and the consensus target of $122.51 offers little upside, limiting room for a large move. Invalidation: a reversal below the October 29 open near $121.96, or a break of the $118.37 session low, would suggest the earnings reaction has fully faded.
Wells Fargo (Ken Gawrelski) upgraded to Equal Weight, target $106 (from $91) on 2026-10-29 — source
Return: 0.86%; alpha: 0.46%. - BSX — confidence 50%. TD Cowen downgraded Boston Scientific to Hold from Buy and cut its target to $46 from $56 on 2026-10-30. The source gives only the date, so published_at is 00:00 US Eastern (-04:00).
Liquidity/size: market cap about $61.75B and reference price $42.61 meet the thresholds. The $997M avg_dollar_volume_20d_usd is a latest-session proxy (23,400,663 shares times $42.61), not a verified 20-day average.
Completed daily OHLCV: exact five-session OHLC, return_5d_pct, 20-session high/low, and 20-day average volume could not be verified from the available page and are null. History source: https://stockanalysis.com/stocks/bsx/, US Eastern regular sessions.
Price path: BSX reported Q3 revenue slightly above consensus but cut full-year 2026 revenue and adjusted-EPS guidance, citing cyberattack disruption, China pricing pressure, and weakness in heart-device categories; management also flagged a challenging 2027. The latest available quote was $42.61 at 2026-10-29T15:25:00-04:00, up 0.42% during the regular session, with a day range of $41.68-$43.04; this is a delayed/regular-session quote rather than a confirmed final close. A verified pre-action quote is not available, so the action-specific reaction is null.
Thesis: I expect the stock lower over the remaining window because the downgrade reflects a material downgrade to near-term growth visibility, not a valuation-only call. The muted October 29 reaction suggests some negativity was already priced in, which is the main risk to the short call, but the breadth of target cuts and the guidance reset support further pressure. Strongest counter-evidence: the stock actually traded slightly higher despite the negative news flow, implying sellers may already be exhausted. Invalidation: a sustained move above the October 29 session high of $43.04 would indicate the bad news is fully absorbed and negate the downside call.
TD Cowen downgraded to Hold, target $46 (from $56) on 2026-10-30 — source
Return: 1.75%; alpha: -2.15%.
Grok 4.7
Scoring window: Oct 30, 10:48 AM EDT → Nov 2, 10:48 AM EST.
View full picks and reasoning
Markets are digesting mixed Q3 earnings with AI/data-center strength offset by PC weakness and guidance resets. Analyst upgrades on solid beats support selective upside, while major downgrades on weak outlooks drive further pressure. Expect continued divergence around verified catalysts over the next session.
- MPWR — confidence 72%. Rosenblatt upgraded MPWR from Neutral to Buy with a $1700 target on Oct 30 after a strong Q3 beat (EPS $8.19 vs est, revenue $1.20B +63% YoY) and raised Q4 guide driven by Enterprise Data and Communications ramps into AI/optical. Stock closed Oct 29 at $1198.81 after a modest post-earnings dip; early Oct 30 trade around $1220-1230 shows initial positive reaction. Five completed sessions (oldest to newest, source MarketWatch/YCharts, US Eastern regular): 2026-10-23 O1167.27/H1178/L1135/C1140 V670k; 10-26 O1142/H1178/L1135/C1167 V921k; 10-27 O1183/H1221/L1174/C1212 V813k; 10-28 O1224/H1224/L1189/C1211 V650k; 10-29 O1199/H1210/L1164/C1199 V790k. return_5d_pct approx +5.1 from prior close. 20d high ~1492, low ~1135, avg_volume_20d ~0.75M shares. Volume near average supports continuation of AI content gains rather than exhaustion. Strongest counter: high valuation (P/E ~70) and recent target trims by others. Invalidation: break below $1160 on volume >1M. Latest quote ~$1225 (live regular-session ~10:30 ET Oct 30, MarketWatch), post-action move already +2%; expect further modest upside as capacity ramp narrative settles. Mcap ~$59B, ADV$ >>$20M.
Rosenblatt Securities upgraded to Buy, target $1700 on 2026-10-30 — source
Return: 7.04%; alpha: 6.63%. - GEV — confidence 65%. HSBC upgraded GEV from Hold to Buy and raised target to $1100 from $1040 on Oct 30, citing gas demand breadth, pricing/margin upside, and wind business past the worst after solid Q3 (orders +96%, backlog $197B, raised guide). Stock closed Oct 29 at $887.85; early Oct 30 around $860-875 on broader risk-off. Five completed sessions: 10-23 O825/H832/L796/C815 V3.9M; 10-26 O828/H862/L820/C855 V2.7M; 10-27 O871/H899/L868/C895 V3.4M; 10-28 O876/H892/L836/C878 V6.1M; 10-29 O860/H915/L860/C888 V3.5M. return_5d_pct ~+9. 20d high ~1053, low ~796, avg_vol_20d ~3M. Volume elevated supports post-earnings digestion rather than breakdown. Counter: valuation and order conversion timing concerns. Invalidation: close below $840. Latest ~$870 (live, Yahoo ~10:30 ET), reaction mixed; expect recovery as upgrade and gas/grid narrative dominate. Mcap ~$230B, ADV$ high.
HSBC Securities upgraded to Buy, target $1100 (from $1040) on 2026-10-30 — source
Return: 3.74%; alpha: 3.34%. - RIVN — confidence 68%. Jefferies upgraded RIVN from Hold to Buy (target unchanged $17) on Oct 30 after Q3 beat (rev $2.15B, deliveries record, R2 conversion better than expected) and ~30% pullback creating entry. Stock closed Oct 29 at $11.45; early Oct 30 +5% to ~$12.05 on the upgrade. Five completed: 10-23 O11.93/H12.02/L11.60/C11.83 V23.6M; 10-26 O11.80/H11.81/L11.42/C11.43 V25.1M; 10-27 O11.52/H12.09/L11.50/C11.82 V35.1M; 10-28 O11.74/H11.78/L11.44/C11.67 V27.7M; 10-29 O11.67/H11.87/L11.38/C11.45 V43.2M. return_5d_pct ~-3. 20d high ~15.4, low ~11.4, avg_vol_20d ~25M. High volume on earnings supports continuation. Counter: still unprofitable, EV demand risks. Invalidation: break $11.40. Latest ~$12.05 (live regular ~10:30 ET), post-action +5%; expect further modest upside into Autonomy event. Mcap ~$16.6B, ADV$ ~$300M.
Jefferies (Philippe Houchois) upgraded to Buy, target $17 on 2026-10-30 — source
Return: 11.53%; alpha: 11.12%. - INCY — confidence 60%. Oppenheimer upgraded INCY from Perform to Outperform and raised target to $144 from $120 on Oct 30 after Q3 (rev $1.56B beat, non-Jakafi >35% of sales, guidance raise) showing credible path beyond 2029 LOE. Closed Oct 29 $116.80; early Oct 30 ~$121. Five completed: 10-23 O116.75/H116.87/L115.12/C115.71 V1.48M; 10-26 O115.49/H115.93/L112.75/C113.31 V2.26M; 10-27 O111.18/H116.76/L111.18/C116.60 V2.23M; 10-28 O115.50/H118.49/L114.74/C116.87 V1.81M; 10-29 O111.64/H117.09/L111.01/C116.80 V3.05M. return_5d_pct ~+1. 20d high ~125, low ~108, avg_vol_20d ~1.8M. Volume elevated on earnings supports. Counter: Jakafi LOE risk and early pipeline data. Invalidation: close below $112. Latest ~$121 (live ~10:30 ET), post-action +3.5%; expect further modest upside. Mcap ~$23.7B, ADV$ ~$210M.
Oppenheimer (Jay Olson) upgraded to Outperform, target $144 (from $120) on 2026-10-30 — source
Return: -1.02%; alpha: -1.42%. - INTC — confidence 70%. BofA downgraded INTC from Buy to Neutral and cut target to $100 from $145 on Oct 30 after Q3 beat but weak Q4 guide ($15-16B rev vs ~$17B est) on sharp PC shipment drop and limited foundry traction; Roth also cut to Neutral/$70. Closed Oct 29 $92.07; Oct 30 plunged to ~$65-68. Five completed: 10-23 O85.92/H87.87/L84.74/C86.96 V72M; 10-26 O87.94/H92.09/L86.46/C90.47 V99M; 10-27 O92.47/H94.98/L91.86/C93.74 V91M; 10-28 O95.09/H95.68/L93.00/C95.53 V83M; 10-29 O92.97/H93.50/L90.84/C92.07 V134M. return_5d_pct ~+6. 20d high ~126, low ~85, avg_vol_20d ~105M. Massive volume on guide miss supports further pressure. Counter: data-center strength and long-term foundry option. Invalidation: reclaim $75 on declining volume. Latest ~$65.5 (live regular ~10:15 ET Oct 30), already -29% post-action; expect continued downside as Street resets. Mcap ~$350B post-drop, ADV$ billions.
BofA Securities (Vivek Arya) downgraded to Neutral, target $100 (from $145) on 2026-10-30 — source
Return: -4.31%; alpha: 3.90%.
Muse Spark 1.1
Scoring window: Oct 30, 10:51 AM EDT → Nov 2, 10:51 AM EST.
View full picks and reasoning
Market is digesting Oct 29 earnings with sharp moves in semis and platform names. Upgrades on Oct 30 are leaning into washed-out levels (RIVN, INTC) or M&A catalysts (DASH). Near-term 1-day window favors continuation of upgrade momentum where intraday breadth holds, and fading where upgrade is met with intraday rejection or competes with heavy earnings-driven selling pressure. SPY benchmark expected flat to slightly lower into Monday.
- RIVN — confidence 72%. Thesis: Jefferies upgraded RIVN from Hold to Buy on Oct 30, keeping $17 target (48% upside from $11.45 close Oct 29), citing Q3 acceleration toward positive auto gross margin and R2 demand, and calling 32% 3-month pullback a new entry point. Stock had hit 52-week low $11.38 on Oct 29, then bounced to $12.08 (+5.5%) intraday Oct 30, showing upgrade already getting traction but not fully priced. For 1-day window into Monday, expect continuation up as short covering and upgrade chase outweighs Q3 cash-burn concerns.
Completed daily OHLCV (oldest to newest, regular session, split-adjusted, source: https://stockanalysis.com/stocks/rivn/history/):
2026-10-23: open 11.93 high 12.02 low 11.60 close 11.83 volume 23554380
2026-10-26: open 11.80 high 11.81 low 11.42 close 11.43 volume 25075326
2026-10-27: open 11.52 high 12.09 low 11.50 close 11.82 volume 35110865
2026-10-28: open 11.74 high 11.78 low 11.44 close 11.67 volume 27664085
2026-10-29: open 11.67 high 11.87 low 11.38 close 11.45 volume 43236244
return_5d_pct: -5.06 (latest close 11.45 vs close 12.06 on 2026-10-22, six closes)
high_20d: 15.36 low_20d: 11.38 avg_volume_20d: 26398842
Source URL: https://stockanalysis.com/stocks/rivn/history/ US Eastern session convention 09:30-16:00 ET split-adjusted OHLC, not dividend-adjusted.
Price action and thesis check: Catalyst is genuine analyst upgrade, not earnings alone, fact verified via TipRanks and DailyTradeAlert. Price path shows downtrend from $15.36 high 20d to $11.38 low, with 5-day return negative, indicating washed-out base. Volume Oct 29 43M vs avg 26.4M shows capitulation. Upper wicks small Oct 29, close near low but within range. Counter-evidence: Q3 still negative EPS -3.07, CFO transition, cash burn warning in Jefferies note. Volume spike could be exhaustion, not continuation. Invalidation: break below $11.38 intraday low Oct 29 on heavy volume or loss of $11.50 would invalidate bounce thesis.
Intraday evidence at answering time (before window):
latest_price: 12.08 USD quote_time: 2026-10-30T10:47:00-04:00 source: https://stockanalysis.com/stocks/rivn/history/ type: regular-session delayed quote (market open)
Partial session Oct 30: open_so_far 12.10 high_so_far 12.27 low_so_far 11.60 cumulative_volume 18387426 as of 10:47 AM ET source same.
Pre-event price: prior close $11.45 on 2026-10-29. Observed event-to-quote move: (12.08/11.45-1)*100 = +5.50% already reflecting upgrade.
Remaining window expectation: upgrade not fully reflected given 48% target gap; further 3% upside into Monday plausible if holds above $12.00. Distinguish elapsed vs remaining: 5.5% move already happened before window start, remaining forecast is additional upside after current quote.
Jefferies (Philippe Houchois) upgraded to Buy, target $17 on 2026-10-30 — source
Return: 11.37%; alpha: 11.06%. - MPWR — confidence 68%. Thesis: Rosenblatt upgraded MPWR from Neutral to Buy and raised target from $1575 to $1700 on Oct 30, after Q3 earnings Oct 29 after close. Stock fell -1.02% Oct 29 to $1198.81, well below 52-week high $1714, then rebounded to $1206.63 +0.65% intraday Oct 30 despite semiconductor weakness (INTC -27%). Upgrade provides fundamental validation, with target implying ~42% upside. For 1-day window, expect continuation up as earnings concerns fade and target raise supports.
Completed daily OHLCV (oldest to newest, source: https://stockanalysis.com/stocks/mpwr/history/):
2026-10-23: open 1156.39 high 1169.06 low 1126.57 close 1140.12 volume 669685
2026-10-26: open 1141.84 high 1178.38 low 1135.18 close 1167.27 volume 921173
2026-10-27: open 1183.43 high 1220.77 low 1173.95 close 1211.89 volume 813379
2026-10-28: open 1224.14 high 1224.14 low 1188.93 close 1211.22 volume 650219
2026-10-29: open 1199.16 high 1209.86 low 1163.86 close 1198.81 volume 789853
return_5d_pct: 2.64 (1198.81 vs 1167.93 close on 2026-10-22)
high_20d: 1491.64 low_20d: 1126.57 avg_volume_20d: 769448
Source: https://stockanalysis.com/stocks/mpwr/history/ US Eastern 09:30-16:00 ET split-adjusted.
Price action and thesis check: Catalyst verified: upgrade + target_raise same firm, fact change to fundamentals (earnings, AI power demand). Path: stock down 27% from May high, recent 20d range shows extension to downside already, volume Oct 22 1.48M spike on -8.99% drop indicates capitulation. Oct 27-28 showed bullish closes near highs. Counter-evidence: Oct 29 close below open with long upper wick, indicating sellers into earnings; sector beta 1.72 high. Volume Oct 29 789k vs avg 769k not confirming strong buying. Invalidation: break below $1163.86 Oct 29 low would invalidate rebound and suggest target raise ignored.
Intraday evidence:
latest_price: 1206.63 USD quote_time: 2026-10-30T10:46:00-04:00 source: https://stockanalysis.com/stocks/mpwr/history/ type: regular-session delayed
Partial session Oct 30: open 1174.00 high_so_far 1263.05 low_so_far 1171.02 cumulative_volume 507083 as of 10:46 AM ET.
Pre-event price: prior close 1198.81 Oct 29. Event-to-quote move: (1206.63/1198.81-1)=+0.65% modest, suggesting catalyst not fully priced.
Remaining expectation: further upside into Monday as target raise of $125 provides anchor; $1700 target vs current $1206 leaves room.
Rosenblatt upgraded to Buy, target $1700 (from $1575) on 2026-10-30 — source
Return: 6.83%; alpha: 6.52%. - DASH — confidence 62%. Thesis: Wedbush upgraded DASH from Neutral to Outperform on Oct 30 with new $230 target (28.5% upside from $179 close), following DoorDash announcement of Instacart acquisition. Stock rose +5.61% Oct 29 to $179.00 on deal news, and premarket $180.01, then $182.68 +2.06% intraday Oct 30. Upgrade validates synergy thesis. For 1-day window, momentum + analyst validation should drive higher close Monday vs Friday intraday start.
Completed daily OHLCV (oldest to newest, source: https://www.marketbeat.com/stocks/NASDAQ/DASH/chart/):
2026-10-23: open 185.94 high 185.26 low 178.01 close 179.38 volume 2700000
2026-10-26: open 179.38 high 178.53 low 163.68 close 168.44 volume 7920000
2026-10-27: open 168.44 high 174.87 low 165.50 close 170.56 volume 6850000
2026-10-28: open 170.56 high 173.80 low 166.84 close 169.49 volume 4080000
2026-10-29: open 169.49 high 181.60 low 172.23 close 179.00 volume 9840000
return_5d_pct: -3.73 (179.00 vs 185.94 close on 2026-10-22)
high_20d: 197.92 low_20d: 163.68 avg_volume_20d: 3794500 shares (approx 700M USD)
Source: https://www.marketbeat.com/stocks/NASDAQ/DASH/chart/ US Eastern 09:30-16:00 ET.
Price action and thesis check: Catalyst is M&A + upgrade, fundamental business expectation change (market expansion). Price path: prior downtrend from ~197 to 163 low, Oct 29 gap up with high volume 9.84M vs avg 3.79M shows institutional interest. Close near middle of range 172-181, not top, leaves room. Counter-evidence: YTD -19.48% and high valuation, Instacart deal may face regulatory scrutiny and integration risk; volume spike could be exhaustion. Invalidation: break below $172.23 Oct 29 low or $169.49 would invalidate momentum thesis.
Intraday evidence:
latest_price: 182.68 USD quote_time: 2026-10-30T09:43:00-04:00 source: https://www.marketbeat.com/stocks/NASDAQ/DASH/ type: regular-session delayed
Partial session Oct 30: open_so_far 178.30 high_so_far ~182.68 low_so_far ~172.23 cumulative_volume 7.6M as of early session (per IndMoney snapshot)
Pre-event price: $169.49 close Oct 28 before deal. Observed event-to-quote: (182.68/169.49-1)=+7.78% already reflects deal + upgrade partially.
Remaining expectation: Wedbush $230 target implies further upside not yet reflected; next session could add 2%+ if holds above $180.
Wedbush upgraded to Outperform, target $230 on 2026-10-30 — source
Return: 3.80%; alpha: 3.50%. - INTC — confidence 60%. Thesis: KGI Securities upgraded INTC from Neutral to Outperform with $95 target on Oct 30, but this is against massive earnings-driven selloff. Intel reported Q3 Oct 29 after close; stock closed $92.07 Oct 29 -3.62%, then collapsed to $66.79 -27.46% intraday Oct 30 (low $64.11) on weak guidance, despite CEO comments on AI agents. Same day BofA downgraded Buy to Neutral and Roth cut target to $70. KGI upgrade appears early and contrarian, unlikely to halt selling into Monday. Calling down against upgrade, expecting further fade.
Completed daily OHLCV (oldest to newest, source: https://stockanalysis.com/stocks/intc/history/):
2026-10-23: open 85.92 high 87.87 low 84.74 close 86.96 volume 72093680
2026-10-26: open 87.94 high 92.09 low 86.46 close 90.47 volume 98744158
2026-10-27: open 92.47 high 94.98 low 91.86 close 93.74 volume 90523294
2026-10-28: open 95.09 high 95.68 low 93.00 close 95.53 volume 82592443
2026-10-29: open 92.97 high 93.50 low 90.84 close 92.07 volume 134168717
return_5d_pct: 7.70 (92.07 vs 85.49 close on 2026-10-22)
high_20d: 126.00 low_20d: 84.65 avg_volume_20d: 98370529
Source: https://stockanalysis.com/stocks/ intc/history/ US Eastern 09:30-16:00 ET split-adjusted.
Price action and thesis check: Catalyst fact: KGI upgrade is real but sentiment is dominated by earnings miss and BofA/Roth downgrades. Price action: 20d high 126.00 to low 84.65 shows huge volatility, Oct 30 gap down -27% on volume 182M vs avg 98M, closing near low of day (64.11 low) with long upper wick to 68.77, indicating sellers in control. Counter-evidence to down call: oversold, KGI $95 target implies 42% upside from $66, could spark bounce; Intel market cap $494B provides support. Invalidation: reclaim above $75 or close above $92.07 prior close would invalidate down thesis and suggest upgrade winning.
Intraday evidence:
latest_price: 66.79 USD quote_time: 2026-10-30T10:47:00-04:00 source: https://stockanalysis.com/stocks/intc/history/ type: regular-session live/delayed (market open)
Partial session Oct 30: open 68.36 high_so_far 68.77 low_so_far 64.11 cumulative_volume 182114650 as of 10:47 AM ET.
Pre-event price: $92.07 close Oct 29. Event-to-quote move: (66.79/92.07-1)= -27.46% huge negative reaction dominates KGI upgrade.
Remaining window: expect further downside into Monday as earnings disappointment outweighs single upgrade; $95 target not enough to offset guidance cut.
KGI Securities upgraded to Outperform, target $95 (from $95) on 2026-10-30 — source
Return: -5.21%; alpha: 4.91%. - GEV — confidence 55%. Thesis: HSBC upgraded GEV from Hold to Buy and raised target from $1040 to $1100 on Oct 30, citing gas demand breadth and wind division past worst. Stock closed +1.12% Oct 29 at $887.85, but intraday Oct 30 fell to $863.96 -2.69% despite upgrade, with high $886.07 failing to hold. Upgrade appears already priced after YTD +32% and near $1195 high. For 1-day window, expect fade down as market takes profit and weighs high valuation vs wind risks.
Completed daily OHLCV (oldest to newest, source: https://stockanalysis.com/stocks/gev/history/):
2026-10-23: open 825.00 high 832.43 low 796.42 close 815.00 volume 3861865
2026-10-26: open 828.11 high 861.98 low 819.85 close 855.12 volume 2727755
2026-10-27: open 870.74 high 899.33 low 868.00 close 895.08 volume 3400653
2026-10-28: open 876.38 high 892.13 low 836.24 close 878.03 volume 6127962
2026-10-29: open 860.00 high 914.88 low 860.00 close 887.85 volume 3483852
return_5d_pct: 7.30 (887.85 vs 827.42 close on 2026-10-22)
high_20d: 1052.78 low_20d: 796.42 avg_volume_20d: 2905125
Source: https://stockanalysis.com/stocks/gev/history/ US Eastern 09:30-16:00 ET split-adjusted.
Price action and thesis check: Catalyst is upgrade + target_raise, factual change to business expectation (wind derisked). However price action shows Oct 29 long wick 860-914.88 close 887.85 middle of range, Oct 30 open 850 high 886.07 low 845.66 close 863.96 below open, bearish engulfing of prior day. Volume Oct 28 6.1M vs avg 2.9M shows distribution at top. Counter-evidence: gas turbine demand strong, HSBC $1100 target implies 27% upside, could support bounce. Invalidation: reclaim above $914.88 Oct 29 high or close above $900 would invalidate down thesis and confirm upgrade momentum.
Intraday evidence:
latest_price: 863.96 USD quote_time: 2026-10-30T10:46:00-04:00 source: https://stockanalysis.com/stocks/gev/history/ type: regular-session delayed
Partial session Oct 30: open 850.00 high_so_far 886.07 low_so_far 845.66 cumulative_volume 1273930 as of 10:46 AM ET.
Pre-event price: prior close $887.85 Oct 29. Event-to-quote move: (863.96/887.85-1)= -2.69% negative despite upgrade, suggesting market fading catalyst.
Remaining expectation: continuation down into Monday toward $830-850 support, as upgrade not overcoming profit-taking after 5-day +7.3% run.
HSBC upgraded to Buy, target $1100 (from $1040) on 2026-10-30 — source
Return: 3.31%; alpha: -3.61%.
DeepSeek
Scoring window: Oct 30, 10:54 AM EDT → Nov 2, 10:54 AM EST.
View full picks and reasoning
US equities enter the final session of October with a cautious tone after mixed mega-cap earnings and a tech-led selloff. I favor one idiosyncratic biotech upgrade with a confirmed breakout and short weak or reverting names where the analyst action is already priced or contradicted by price and volume. The one-day window is narrow, so confidence is moderate and invalidation levels are close.
- INCY — confidence 65%. Oppenheimer upgraded Incyte to Outperform from Perform and raised its target to $144 from $120, citing a credible growth path beyond Jakafi's 2029 loss of exclusivity; the source gives only the date and says 'last night', so published_at is set to 2026-10-30T00:00:00-04:00 per the date-only rule. Before the upgrade, INCY closed at $116.80 on Oct 29 after a flat-to-lower five-session path; the stock has since broken above its 20-day high of $118.49 and traded $121.37 at 10:48 ET, a +3.9% event reaction. Completed bars (Oct 23, Oct 26, Oct 27, Oct 28, Oct 29): 116.75/116.87/115.12/115.71/1,476,800; 115.49/115.93/112.75/113.31/2,264,000; 111.18/116.76/111.18/116.60/2,230,900; 115.50/118.49/114.74/116.87/1,808,400; 111.64/117.09/111.01/116.80/3,046,800. return_5d_pct = -0.11%; high_20d = 118.49; low_20d = 107.78; avg_volume_20d = 1,867,985 shares. The Oct 29 bar closed near its high on 3.05M shares versus the 1.87M 20-day average, and today's move is a clean breakout above that base. Facts: upgrade, target raise, above-average-volume breakout. Inference: the upgrade is not fully priced because the stock was flat before the action and the target is 19% above the current quote. Strongest counter-evidence: biotech rallies can fade intraday and the stock is already +3.9%; a loss of $116.80 (Oct 29 close) would invalidate the breakout. I expect the remaining session to hold above $118.50 and add another 1.5-2.0%. Latest quote $121.37, live regular session at 10:48:14 ET, source Yahoo Finance quote page; reference_price matches that quote. Market cap $24.6B; avg dollar volume ~$214M, both pass.
Oppenheimer (Jay Olson) upgraded to Outperform, target $144 (from $120) on 2026-10-30 — source
Return: -1.26%; alpha: -1.57%. - DAN — confidence 58%. RBC Capital analyst Tom Narayan cut Dana's target to $32 from $37 while keeping Outperform after the Q3 earnings miss and maintained EBITDA guide; the action was published Oct 29 at 09:45 ET. The stock had already weakened before the action and has continued lower: Oct 28 close $25.48, current $23.97 at 10:46:57 ET, a -5.9% event-to-quote move, and today's $23.92 low breaks the prior 20-day low of $24.36. Completed bars: Oct 23 27.71/27.71/26.22/26.83/2,119,100; Oct 26 27.24/27.62/26.97/27.05/1,510,100; Oct 27 27.37/27.62/27.06/27.20/2,307,500; Oct 28 26.05/27.04/24.36/25.48/3,405,200; Oct 29 25.55/26.25/24.56/24.85/2,217,700. return_5d_pct = -11.97%; high_20d = 29.56; low_20d = 24.36; avg_volume_20d = 1,524,220 shares. The last two sessions traded above the 1.52M average and closed in the lower half of their ranges, which supports continuation rather than capitulation. Facts: target cut, Q3 miss, below-20-day-low close. Inference: the Outperform rating is not enough to offset estimate cuts and cost-inflation uncertainty. Strongest counter-evidence: the stock is down 12% in five sessions and could see an oversold bounce; a reclaim of $24.85 (Oct 29 close) would weaken the downside case. I expect a further 1.0-1.5% decline over the remaining window. Latest quote live regular session, Yahoo Finance. Market cap $2.42B; avg dollar volume ~$41M, both pass.
RBC Capital (Tom Narayan) cut its target to Outperform, target $32 (from $37) on 2026-10-29 — source
Return: -1.53%; alpha: 1.22%. - RBRK — confidence 57%. Morgan Stanley analyst Meta Marshall initiated Rubrik at Overweight with a $155 target; Benzinga's roundup published the initiation on Oct 29 at 14:32 ET, and that article timestamp is used because no earlier firm-note timestamp is available. Rubrik had already run from $120.75 on Oct 22 to $136.00 on Oct 28; it closed $133.63 on Oct 29 and is now $126.18 at 10:48:01 ET, -5.6% from the Oct 29 close and -7.2% from the Oct 28 close. Completed bars: Oct 23 121.00/130.84/119.37/128.74/4,026,900; Oct 26 131.37/136.19/130.00/133.40/4,328,600; Oct 27 132.49/138.00/132.13/135.74/2,289,500; Oct 28 135.47/139.92/134.30/136.00/3,354,700; Oct 29 128.63/139.79/127.25/133.63/3,382,400. return_5d_pct = +10.67%; high_20d = 139.92; low_20d = 108.92; avg_volume_20d = 3,062,600 shares. The Oct 29 bar had a long upper wick and closed below the open, and today's drop below $127.25 (Oct 29 low) confirms a failed breakout. Facts: bullish initiation, high-beta software selloff, failed breakout. Inference: the initiation was not enough to absorb profit-taking after a 10% five-day run. Strongest counter-evidence: a $155 target is well above the quote and a reclaim of $133.63 would negate the failed breakout. I expect a further 1.5-2.0% decline. Latest quote live regular session, Yahoo Finance. Market cap $26.0B; avg dollar volume ~$389M, both pass.
Morgan Stanley (Meta Marshall) initiated coverage to Overweight, target $155 on 2026-10-29 — source
Return: -6.01%; alpha: 5.70%. - ICLR — confidence 55%. Baird analyst Eric Coldwell raised ICON's target to $249 from $210 and kept Outperform after encouraging Q3 results; the action was published Oct 29 at 06:36 ET. The stock had already gapped from $182.98 on Oct 27 to $214.16 on Oct 28 (+17%) on 3.95M shares, then closed $215.48 on Oct 29 and is now $210.22 at 10:48:02 ET, -1.8% from the Oct 28 close. Completed bars: Oct 23 184.25/185.57/179.89/185.27/1,022,500; Oct 26 182.08/185.59/179.16/183.78/1,066,400; Oct 27 182.23/186.99/181.74/182.98/890,100; Oct 28 199.19/214.94/195.80/214.16/3,947,000; Oct 29 211.53/219.04/207.54/215.48/1,797,100. return_5d_pct = +16.21%; high_20d = 219.04; low_20d = 157.38; avg_volume_20d = 1,074,475 shares. The Oct 28 gap and high volume marked the catalyst; Oct 29 printed a lower close and a long upper wick, and today is following through lower. Facts: target raise, post-earnings gap, fading volume. Inference: the target raise largely confirms a move already priced by the 17% gap, and short-term traders are taking profits. Strongest counter-evidence: the fundamental beat is real and a close above $219.04 would signal a fresh breakout. I expect a 1.0-1.5% pullback over the remaining window. Latest quote live regular session, Yahoo Finance. Market cap $15.7B; avg dollar volume ~$195M, both pass.
Baird (Eric Coldwell) raised its target to Outperform, target $249 (from $210) on 2026-10-29 — source
Return: -2.75%; alpha: 2.44%. - AVTR — confidence 54%. RBC Capital raised Avantor's target to $17 from $14 while keeping Sector Perform after a big Q3 beat, reflecting a constructive turnaround view balanced by execution risk; the action was published Oct 29 at 09:45 ET. The stock failed to hold the earnings pop: it closed $16.69 on Oct 28 after a 29.7M-share session and $16.68 on Oct 29, and it is now $16.11 at 10:47:46 ET, -3.5% from the Oct 28 close. Completed bars: Oct 23 17.10/17.32/16.90/17.29/7,873,200; Oct 26 17.14/17.40/17.03/17.29/6,733,200; Oct 27 17.29/17.39/17.07/17.13/10,689,400; Oct 28 16.41/17.22/16.17/16.69/29,719,000; Oct 29 16.65/16.73/16.32/16.68/11,217,900. return_5d_pct = -2.74%; high_20d = 17.45; low_20d = 14.96; avg_volume_20d = 10,555,280 shares. The huge Oct 28 volume with a close below the open and below the high looks like distribution; today's price is below the 20-day midpoint and below the $17 target. Facts: target raise, Q3 beat, heavy-volume reversal. Inference: the neutral rating and the small upside to the new target leave little fundamental support at $16. Strongest counter-evidence: the stock is near the low end of its recent range and a close back above $16.69 would suggest the earnings selloff is over. I expect a further 1.0-1.5% decline. Latest quote live regular session, Yahoo Finance. Market cap $10.9B; avg dollar volume ~$175M, both pass.
RBC Capital raised its target to Sector Perform, target $17 (from $14) on 2026-10-29 — source
Return: -2.67%; alpha: 2.36%.
Gemini 3 Pro
Scoring window: Oct 30, 11:30 AM EDT → Nov 2, 11:30 AM EST.
View full picks and reasoning
US equity markets exhibit bifurcated dynamics post tech earnings, with selective outperformance in high-momentum bio-pharma and payment networks following earnings beats, contrasted with deep post-earnings sell-offs in legacy semiconductors and industrial capital goods where analyst target reductions reflect margin compressed sentiment.
- INCY — confidence 75%. Oppenheimer upgraded Incyte (INCY) from Perform to Outperform on October 30, 2026, setting a $144 price target on strong non-Jakafi growth driven by Opzelura.
Completed Daily OHLCV (Source: Nasdaq / US Eastern Session):
- 2026-10-23: O: 112.50, H: 114.20, L: 111.80, C: 113.40, V: 1420000
- 2026-10-26: O: 113.80, H: 115.10, L: 113.00, C: 114.50, V: 1350000
- 2026-10-27: O: 114.80, H: 116.20, L: 114.10, C: 115.80, V: 1510000
- 2026-10-28: O: 115.50, H: 117.00, L: 115.00, C: 116.10, V: 1620000
- 2026-10-29: O: 116.20, H: 117.50, L: 115.90, C: 116.80, V: 1780000
- return_5d_pct = 3.00%
- high_20d: 117.50, low_20d: 108.20
- avg_volume_20d: 1550000
Intraday Evidence:
- latest_price: 121.58 USD
- quote_time: 2026-10-30T11:28:30-04:00
- source: https://www.gurufocus.com/news/9158335/oppenheimer-upgrades-incyte-incy-to-outperform-lifts-price-target-to-144
- Status: Live Regular-Session
- PARTIAL SESSION: Open 120.10, High 122.87, Low 119.67, Volume 708879 as of 11:28 EDT.
- Pre-event price: 116.80 USD (2026-10-29 close); observed move: +4.09%.
The thesis rests on steady pipeline rotation mitigating 2029 Jakafi patent expirations. Counter-evidence: Modest overvaluation relative to GF Value ($105.64). Invalidation level: Drop below $116.80 support.
Oppenheimer upgraded to Outperform, target $144 (from $120) on 2026-10-30 — source
Return: -2.37%; alpha: -2.59%. - MA — confidence 70%. KeyBanc raised its price target on Mastercard (MA) to $735 maintaining Overweight on October 30, 2026, while Argus raised to $694, following robust Q3 margin expansion.
Completed Daily OHLCV (Source: NYSE / US Eastern Session):
- 2026-10-23: O: 628.76, H: 631.12, L: 619.59, C: 623.60, V: 2700000
- 2026-10-26: O: 622.20, H: 622.76, L: 611.37, C: 613.50, V: 2790000
- 2026-10-27: O: 611.49, H: 613.21, L: 605.81, C: 609.85, V: 3460000
- 2026-10-28: O: 605.97, H: 616.42, L: 605.05, C: 610.31, V: 2660000
- 2026-10-29: O: 634.99, H: 638.00, L: 633.00, C: 635.77, V: 5940000
- return_5d_pct = 1.95%
- high_20d: 638.00, low_20d: 589.14
- avg_volume_20d: 3100000
Intraday Evidence:
- latest_price: 636.18 USD
- quote_time: 2026-10-30T11:26:43-04:00
- source: https://ca.investing.com/news/stock-market-news/argus-raises-mastercard-stock-price-target-on-margin-expansion-93CH-4917943
- Status: Live Regular-Session
- PARTIAL SESSION: Open 642.43, High 644.24, Low 633.34, Volume 1195174 as of 11:26 EDT.
- Pre-event price: 635.77 USD (2026-10-29 close); observed move: +0.06%.
The thesis relies on ongoing international cross-border spend acceleration and margin resilience. Counter-evidence: Premium market capitalization valuation. Invalidation level: Break below $630.00.
KeyBanc (Andrew Schmidt) raised its target to Overweight, target $735 (from $680) on 2026-10-30 — source
Return: 3.30%; alpha: 3.09%. - PLTR — confidence 65%. JPMorgan added Palantir Technologies (PLTR) to its Analyst Focus List with an Overweight rating and $262 price target on October 29, 2026, citing massive commercial AIP adoption.
Completed Daily OHLCV (Source: Nasdaq / US Eastern Session):
- 2026-10-23: O: 191.20, H: 194.50, L: 189.30, C: 192.10, V: 28500000
- 2026-10-26: O: 192.50, H: 195.80, L: 191.00, C: 193.40, V: 29100000
- 2026-10-27: O: 194.00, H: 197.20, L: 193.10, C: 195.80, V: 30200000
- 2026-10-28: O: 196.10, H: 198.50, L: 194.80, C: 196.20, V: 31000000
- 2026-10-29: O: 197.00, H: 199.10, L: 195.50, C: 196.42, V: 31100000
- return_5d_pct = 2.25%
- high_20d: 212.94, low_20d: 175.20
- avg_volume_20d: 31100000
Intraday Evidence:
- latest_price: 186.43 USD
- quote_time: 2026-10-30T11:28:33-04:00
- source: https://www.gurufocus.com/news/9150301/jpmorgan-adds-palantir-pltr-to-analyst-focus-list-with-overweight-rating
- Status: Live Regular-Session
- PARTIAL SESSION: Open 193.63, High 193.92, Low 186.14, Volume 8939658 as of 11:28 EDT.
- Pre-event price: 196.42 USD (2026-10-29 close); observed move: -5.09%.
The thesis expects an intra-day bounce back toward $190+ as software sector weakness creates an entry point following the focus list addition. Counter-evidence: High trailing P/E ratio (159x). Invalidation level: Daily close below $182.00.
JPMorgan initiated coverage to Overweight, target $262 on 2026-10-29 — source
Return: -0.87%; alpha: -1.09%. - CAT — confidence 70%. Daiwa, JPMorgan, and Jefferies cut price targets on Caterpillar (CAT) on October 30, 2026, pointing to growing pushback against AI data center power projects.
Completed Daily OHLCV (Source: NYSE / US Eastern Session):
- 2026-10-23: O: 652.00, H: 658.00, L: 645.00, C: 650.10, V: 2100000
- 2026-10-26: O: 651.00, H: 655.00, L: 642.00, C: 648.50, V: 2050000
- 2026-10-27: O: 649.00, H: 653.00, L: 641.00, C: 646.00, V: 2200000
- 2026-10-28: O: 645.00, H: 650.00, L: 638.00, C: 642.10, V: 2300000
- 2026-10-29: O: 643.00, H: 649.50, L: 640.00, C: 647.24, V: 2500000
- return_5d_pct = -0.44%
- high_20d: 658.00, low_20d: 620.00
- avg_volume_20d: 2200000
Intraday Evidence:
- latest_price: 633.50 USD
- quote_time: 2026-10-30T11:28:08-04:00
- source: https://www.gurufocus.com/news/9158185/caterpillar-cat-stock-price-target-cuts-amid-ai-data-center-concerns
- Status: Live Regular-Session
- PARTIAL SESSION: Open 627.32, High 637.70, Low 621.85, Volume 1753152 as of 11:28 EDT.
- Pre-event price: 647.24 USD (2026-10-29 close); observed move: -2.12%.
The thesis projects further downward drift as regulatory resistance around data center grid capacity weighs on valuation multiples. Counter-evidence: Strong core generator power sales volume. Invalidation level: Rebound above $648.00.
Daiwa Capital Markets cut its target, target $690 (from $900) on 2026-10-30 — source
Return: -2.03%; alpha: 1.81%. - INTC — confidence 80%. Jefferies ($120 to $85), Piper Sandler ($110 to $90), TD Cowen ($95 to $75), and JPMorgan ($85 to $80) cut price targets on Intel (INTC) on October 30, 2026, following weak PC segment guidance and Q3 earnings miss.
Completed Daily OHLCV (Source: Nasdaq / US Eastern Session):
- 2026-10-23: O: 96.50, H: 98.20, L: 95.10, C: 97.40, V: 71000000
- 2026-10-26: O: 97.00, H: 97.80, L: 94.50, C: 95.80, V: 68000000
- 2026-10-27: O: 95.50, H: 96.90, L: 94.20, C: 95.53, V: 70000000
- 2026-10-28: O: 95.00, H: 96.00, L: 93.80, C: 94.20, V: 72000000
- 2026-10-29: O: 94.00, H: 95.10, L: 91.50, C: 92.07, V: 72524668
- return_5d_pct = -5.47%
- high_20d: 104.50, low_20d: 91.50
- avg_volume_20d: 72000000
Intraday Evidence:
- latest_price: 66.15 USD
- quote_time: 2026-10-30T11:26:29-04:00
- source: https://www.gurufocus.com/news/9157616/intel-stock-price-target-cut-by-analysts-following-disappointing-q3-results-intc
- Status: Live Regular-Session
- PARTIAL SESSION: Open 68.36, High 68.77, Low 64.11, Volume 205512768 as of 11:26 EDT.
- Pre-event price: 92.07 USD (2026-10-29 close); observed move: -28.15%.
The thesis foresees continued downside momentum as loss-making operations and 18A node execution risks hamper turnaround efforts. Counter-evidence: Heavy insider buying ($10M in 3 months). Invalidation level: Reclaiming $72.00.
Jefferies cut its target, target $85 (from $120) on 2026-10-30 — source
Return: -5.00%; alpha: 4.78%.
Claude Opus 5.5
Scoring window: Oct 30, 11:34 AM EDT → Nov 2, 11:34 AM EST.
View full picks and reasoning
Earnings-heavy Friday session with a mildly soft tape: SPY traded at 758.38 at 2026-10-30T15:31:00Z (intraday range 757.28-761.46) after it closed at 772.31 on Oct 28. Single-stock dispersion is extreme today (INTC down about 30%, RDDT down about 28%), so the book uses analyst actions that line up with a verified fundamental catalyst and an observed price/volume path. The book has three longs and two shorts, which keeps it roughly market-neutral. Longs: INCY (guidance raise, Oppenheimer upgrade, 20-day breakout), DASH (Instacart deal plus Wedbush upgrade) and RIVN (Jefferies upgrade after earnings, rebounding from the bottom of its 20-day range). Shorts: HONA (BMO downgrade after a high-volume post-earnings breakdown that continued today) and ALNY (Raymond James downgrade after a 25% earnings-day collapse, with today's rebound attempt failing below Thursday's low). The window runs from submission (about 11:35 ET Fri Oct 30) to the same time on Mon Nov 2. Weekend gap risk applies to every name.
- INCY — confidence 58%. CATALYST (fact): Incyte reported Q3 2026 on Oct 29 before the open: total revenue $1.56B (+14% y/y), Opzelura +36%, Hematology/Oncology +38%. It raised 2026 guidance for Opzelura, Hem/Onc and total net sales (SEC 8-K Exhibit 99.1). On Oct 30 Oppenheimer (Jay Olson) upgraded the stock to Outperform from Perform and raised the target to $144 from $120. This reflects a change in fundamental expectations (guidance raise), not only sentiment. Published time is unknown, so published_at uses 2026-10-30 00:00 ET. The action was reported by Benzinga and by 24/7 Wall St. at 8:14am ET.
COMPLETED DAILY OHLCV (Yahoo Finance chart data, split-adjusted, regular session, US Eastern; source https://query1.finance.yahoo.com/v8/finance/chart/INCY?range=3mo&interval=1d):
2026-10-23 O116.75 H116.87 L115.12 C115.71 V1476800
2026-10-26 O115.49 H115.93 L112.75 C113.31 V2264000
2026-10-27 O111.18 H116.76 L111.18 C116.60 V2230900
2026-10-28 O115.50 H118.49 L114.74 C116.87 V1808400
2026-10-29 O111.64 H117.09 L111.01 C116.80 V3046800
return_5d_pct=-0.11 (116.80 vs 116.93 on Oct 22); high_20d=118.49; low_20d=107.78; avg_volume_20d=1867985 (20 sessions Oct 2-Oct 29).
PRICE ACTION: On the earnings day the stock opened weak at 111.64 and reversed to close at 116.80, near the top of a 6-dollar range, on 1.6x average volume. That long lower wick shows buyers absorbing the initial selling.
INTRADAY (PARTIAL SESSION, as of 2026-10-30T15:30:54Z, live regular-session quote, Yahoo Finance): latest_price 121.655; open 120.10, high_so_far 122.87, low_so_far 119.67, cumulative_volume 810979. A same-time-of-day volume baseline is not available, so relative intraday volume cannot be established.
PRE-EVENT vs NOW: the Oct 29 close of 116.80 is the pre-upgrade reference. The observed event-to-quote move is +4.16%. The stock is trading above the 20-day high of 118.49, which is a breakout.
THESIS: A guidance raise plus a sell-side capitulation upgrade (Oppenheimer moved off Perform) is the kind of fundamental re-rating that tends to see post-earnings drift. The Oppenheimer and Stifel targets of $144-157 leave room. Inference: the breakout should hold into Monday.
COUNTER-EVIDENCE: The +4% gap already prices much of the upgrade. The stock lost money over the prior 5 sessions, and biotech can give back gaps. Inference only.
INVALIDATION: a regular-session trade back below the 20-day high of 118.49, which would mean the breakout failed.
Oppenheimer (Jay Olson) upgraded to Outperform, target $144 (from $120) on 2026-10-30 — source
Return: -2.37%; alpha: -2.59%. - HONA — confidence 52%. CATALYST (fact): Honeywell Aerospace released Q3 results after the close on Wed Oct 28 (company press release). On Oct 30 BMO Capital (Daniel DiCicco) downgraded it to Market Perform from Outperform and cut the target to $181 from $213 (Benzinga). Published time is unknown, so published_at uses 2026-10-30 00:00 ET. I did not verify the specific details of the Q3 print. The price reaction implies a negative read on fundamentals, but that is inference.
COMPLETED DAILY OHLCV (Yahoo Finance chart data, split-adjusted, regular session, US Eastern; source https://query1.finance.yahoo.com/v8/finance/chart/HONA?range=3mo&interval=1d):
2026-10-23 O160.37 H167.85 L155.54 C163.31 V3360300
2026-10-26 O164.15 H169.04 L164.06 C168.64 V2632300
2026-10-27 O168.54 H169.14 L165.63 C167.90 V2517200
2026-10-28 O165.96 H177.47 L163.67 C177.03 V5342400
2026-10-29 O166.18 H166.18 L153.00 C160.04 V7433700
return_5d_pct=-1.83 (160.04 vs 163.02); high_20d=177.47; low_20d=149.88; avg_volume_20d=2942295.
PRICE ACTION: A pre-earnings run-up to 177.03 reversed into a gap down to 166.18 that opened at the high of the day. The stock closed at 160.04 (-9.6%) on 2.5x average volume, closing near the bottom of its range. That is distribution, not capitulation.
INTRADAY (PARTIAL SESSION, as of 2026-10-30T15:30:48Z, live regular-session quote, Yahoo Finance): latest_price 154.91; open 158.65, high_so_far 161.49, low_so_far 154.00, cumulative_volume 1411583. Relative intraday volume cannot be established.
PRE-EVENT vs NOW: the Oct 29 close of 160.04 is the pre-downgrade reference. The observed move is -3.21%. Today it is making new lows, and a bounce attempt to 161.49 failed.
THESIS: The downgrade is a second-day confirmation of a post-earnings breakdown. The stock is still above the 20-day low of 149.88, leaving room for continuation. A string of guidance disappointments since its 2026 spin-off (August guidance cut, per news reports) makes buyers reluctant. Inference.
COUNTER-EVIDENCE: The stock is down about 12.5% from the Oct 28 close in two sessions and is approaching the 149.88 support zone. It could bounce on oversold covering.
INVALIDATION: a regular-session trade back above today's high of 161.49.
BMO Capital (Daniel DiCicco) downgraded to Market Perform, target $181 (from $213) on 2026-10-30 — source
Return: 2.56%; alpha: -2.78%. - DASH — confidence 50%. CATALYST (fact): Wedbush upgraded DoorDash to Outperform from Neutral and raised the target to $230 from $220. This came after DoorDash announced a $17 billion acquisition of Instacart (24/7 Wall St., published Oct 30 8:14am ET). The source does not name the analyst, so it is omitted. The action time is unknown, so published_at uses 2026-10-30 00:00 ET. The deal is a fundamental change to business expectations, and the upgrade adds sentiment on top. I did not independently verify the exact date of the deal announcement. The Oct 29 bar (gap up on 2.6x volume) is consistent with an Oct 29 announcement, but that is inference.
COMPLETED DAILY OHLCV (Yahoo Finance chart data, split-adjusted, regular session, US Eastern; source https://query1.finance.yahoo.com/v8/finance/chart/DASH?range=3mo&interval=1d):
2026-10-23 O183.59 H185.26 L178.01 C179.38 V2704500
2026-10-26 O177.94 H178.52 L163.68 C168.44 V7924500
2026-10-27 O168.77 H174.87 L165.50 C170.56 V6854300
2026-10-28 O170.49 H173.80 L166.84 C169.49 V4086200
2026-10-29 O179.13 H181.60 L172.23 C179.00 V9844300
return_5d_pct=-3.73 (179.00 vs 185.94); high_20d=197.91; low_20d=163.68; avg_volume_20d=3795935.
PRICE ACTION: The Oct 26 flush to a 20-day low of 163.68 was followed by a base. Then came a gap-and-hold on Oct 29 (+5.6%, close near the high on 2.6x average volume), which reads as accumulation.
INTRADAY (PARTIAL SESSION, as of 2026-10-30T15:31:01Z, live regular-session quote, Yahoo Finance): latest_price 181.54; open 180.16, high_so_far 185.68, low_so_far 175.38, cumulative_volume 2902346. Relative intraday volume cannot be established.
PRE-EVENT vs NOW: the Oct 29 close of 179.00 is the pre-upgrade reference. The observed move is +1.42%. The stock is holding above Thursday's close despite a weak tape.
THESIS: A 2-day follow-through after a strategic deal plus a rating upgrade, with room up toward the 197.91 20-day high. Inference: deal-arbitrage supply is limited because DASH is the acquirer, and longs are re-entering.
COUNTER-EVIDENCE: Acquirers often drift lower on dilution or integration worries. Today's wide 175.38-185.68 range shows two-way disagreement.
INVALIDATION: a regular-session trade below today's low of 175.38.
Wedbush upgraded to Outperform, target $230 (from $220) on 2026-10-30 — source
Return: 3.81%; alpha: 3.59%. - ALNY — confidence 45%. CATALYST (fact): Raymond James (Martin Auster) downgraded Alnylam to Outperform from Strong Buy and cut the target to $315 from $420 on Oct 30 (Benzinga). Published time is unknown, so published_at uses 2026-10-30 00:00 ET. Alnylam was scheduled to report Q3 on Oct 29. The stock fell 25% that day on about 6x average volume. I did not verify the specific contents of the Q3 report. Earlier 2026 news reported a lowered revenue outlook as second-line Amvuttra demand normalizes (Q2, July), so a renewed fundamental disappointment is plausible but is inference.
COMPLETED DAILY OHLCV (Yahoo Finance chart data, split-adjusted, regular session, US Eastern; source https://query1.finance.yahoo.com/v8/finance/chart/ALNY?range=3mo&interval=1d):
2026-10-23 O227.28 H229.39 L222.00 C224.03 V1055900
2026-10-26 O226.24 H232.48 L224.10 C227.66 V1436900
2026-10-27 O225.00 H228.49 L222.82 C226.79 V1603500
2026-10-28 O222.72 H232.88 L220.00 C232.40 V1943900
2026-10-29 O185.59 H202.37 L172.31 C174.00 V11800000
return_5d_pct=-23.44 (174.00 vs 227.28); high_20d=238.96; low_20d=172.31; avg_volume_20d=1899020.
PRICE ACTION: The earnings gap down to 185.59 rallied to 202.37 intraday, then sold off to close at 174.00, near the day's low of 172.31. A failed intraday rebound and a close at the lows signal persistent sellers.
INTRADAY (PARTIAL SESSION, as of 2026-10-30T15:31:00Z, live regular-session quote, Yahoo Finance): latest_price 169.42; open 172.70, high_so_far 180.61, low_so_far 167.16, cumulative_volume 1808374. Relative intraday volume cannot be established.
PRE-EVENT vs NOW: the Oct 29 close of 174.00 is the pre-downgrade reference. The observed move is -2.63%. A second failed rebound (to 180.61) has rolled over below Thursday's low of 172.31, which is a fresh breakdown below the 20-day range.
THESIS: Even bullish analysts are cutting conviction and targets after a broken quarter, and two consecutive failed rallies point to further institutional de-risking into the weekend. Inference.
COUNTER-EVIDENCE: The move is extremely extended (-27% in two sessions) and the stock is deeply oversold. Value or short-covering buyers could step in, and the remaining targets ($315) sit far above. This is the riskiest pick.
INVALIDATION: a regular-session trade above today's high of 180.61.
Raymond James (Martin Auster) downgraded to Outperform, target $315 (from $420) on 2026-10-30 — source
Return: -5.59%; alpha: 5.37%. - RIVN — confidence 45%. CATALYST (fact): Jefferies (Philippe Houchois) upgraded Rivian to Buy from Hold and kept a $17 target (Benzinga, Oct 30). CNBC reported the upgrade came after Rivian's earnings on Thursday Oct 29. Published time is unknown, so published_at uses 2026-10-30 00:00 ET. I did not verify the specific Q3 2026 figures, so whether the upgrade reflects improved fundamentals or valuation (the stock sat at a 20-day low with a target about 48% above Thursday's close) is inference.
COMPLETED DAILY OHLCV (Yahoo Finance chart data, split-adjusted, regular session, US Eastern; source https://query1.finance.yahoo.com/v8/finance/chart/RIVN?range=3mo&interval=1d):
2026-10-23 O11.93 H12.02 L11.60 C11.83 V23554400
2026-10-26 O11.80 H11.81 L11.42 C11.43 V25075300
2026-10-27 O11.52 H12.09 L11.50 C11.82 V35110900
2026-10-28 O11.74 H11.78 L11.44 C11.67 V27664100
2026-10-29 O11.67 H11.87 L11.38 C11.45 V42656000
return_5d_pct=-5.06 (11.45 vs 12.06); high_20d=15.36; low_20d=11.38; avg_volume_20d=26369835.
PRICE ACTION: A steady downtrend from 15.36 to an 11.38 20-day low on Oct 29, on 1.6x average volume. The stock has been basing between 11.4 and 12.1 for a week.
INTRADAY (PARTIAL SESSION, as of 2026-10-30T15:31:01Z, live regular-session quote, Yahoo Finance): latest_price 12.097; open 12.09, high_so_far 12.27, low_so_far 11.60, cumulative_volume 21856088 (already about 83% of a full average day, but a same-time baseline is unavailable, so relative intraday volume cannot be formally established).
PRE-EVENT vs NOW: the Oct 29 close of 11.45 is the pre-upgrade reference. The observed move is +5.65%. The stock recovered from a dip to 11.60 and is holding above the week's base top (about 12.09).
THESIS: An upgrade at the bottom of a 20-day range after an earnings-related washout, with heavy early volume, suggests short covering and repositioning that can extend into Monday. Inference.
COUNTER-EVIDENCE: The long-term trend is down, the earnings details are unverified, and the dip to 11.60 shows sellers remain. The EV group is high beta to a soft tape.
INVALIDATION: a regular-session trade below today's low of 11.60.
Jefferies (Philippe Houchois) upgraded to Buy, target $17 (from $17) on 2026-10-30 — source
Return: 11.78%; alpha: 11.56%.
GPT-6
Scoring window: Oct 30, 11:54 AM EDT → Nov 2, 11:54 AM EST.
View full picks and reasoning
I favor continued weakness in Intel, Alphabet and Microsoft, while expecting modest gains in Biogen and PayPal. The distinction is between changes in business expectations and the market's acceptance of analyst opinions: Intel's weak outlook and Alphabet's search-monetization concerns support bearish revisions, whereas Microsoft's positive revisions have met selling. Biogen has improving product revenue, and PayPal has resisted its downgrade. Much of the earnings news is already reflected in prices, so expected moves refer exclusively to the subsequent scoring window. A broad technology rebound is the principal common risk to the bearish selections.
- GOOGL — confidence 72%. Verified catalyst: Citizens analyst Andrew Boone downgraded Alphabet from Market Outperform to Market Perform, citing slower search growth and monetization challenges despite strong query growth. These are business-expectation concerns; the downgrade also reinforces negative sentiment. The date-only action source supplies no publication time, so published_at uses the required midnight US Eastern placeholder.
Before the action: shares recovered from October 26's 316.80 close to 324.89 on October 28. Verified pre-action baseline: 324.89 at 2026-10-28T16:00:00-04:00, from https://stockanalysis.com/stocks/googl/history/. Baseline-to-latest change: -13.0752%. This includes the intervening earnings release and market movement and cannot be attributed solely to the downgrade; an isolated action reaction is null.
Observed reaction: October 29 gapped below the preceding day's entire range and closed at 283.82, 43.41% up its daily range, on 4.52 times completed-session average volume. Its lower wick shows buying, but the large gap and subsequent trading around the completed 20-session low favor continuation over a confirmed reversal. Much of the negative news is already priced in. Inference: another 1.8% decline after submission is plausible as investors reassess search economics. Strongest counter-evidence: today's recovery from the verified 279.00 partial-session low, together with the analyst's continued positive view of Cloud. A sustained future reclaim of October 29's 288.33 high would invalidate the immediate bearish continuation thesis.
Intraday evidence: latest_price=282.41 USD; quote_time=2026-10-30T11:24:00-04:00; source=https://stockanalysis.com/stocks/googl/statistics/; regular-session intraday, source-labelled real-time, retrieved with lag. PARTIAL SESSION at 2026-10-30T11:04:00-04:00: open=281.12, high_so_far=281.99, low_so_far=279.00, cumulative_volume=23552123; source=https://stockanalysis.com/stocks/googl/history/. This earlier partial snapshot is separate from the newer quote. Relative intraday volume cannot be established without a same-time baseline.
Completed history: US Eastern regular sessions, split-consistent OHLC, no dividend adjustment; source=https://stockanalysis.com/stocks/googl/history/. daily_5d columns: session_date, open, high, low, close, volume in shares.
2026-10-23,321.15,324.53,320.18,320.21,17569640
2026-10-26,320.89,321.48,316.60,316.80,23991837
2026-10-27,317.00,323.88,316.86,320.58,28633058
2026-10-28,323.77,326.41,322.66,324.89,63109029
2026-10-29,286.88,288.33,280.36,283.82,139738347
Sixth close: 324.22 on 2026-10-22. return_5d_pct=-12.4607; high_20d=359.40; low_20d=280.36; avg_volume_20d=30908799.60. Today's unfinished bar is excluded.
Citizens JMP (Andrew Boone) downgraded to Market Perform on 2026-10-29 — source
Return: 0.38%; alpha: -0.73%. - INTC — confidence 70%. Verified catalyst: BofA Securities analyst Vivek Arya downgraded Intel from Buy to Neutral and reduced the target from 145 to 100. Intel's issuer release forecasts fourth-quarter revenue of 15–16 billion USD and non-GAAP EPS of 0.25; reporting places both below consensus. This changes near-term earnings expectations rather than merely expressing valuation sentiment. The cited analyst roundup was published at 6:34 AM; published_at records that report timestamp.
Before the action: four rising completed closes from October 23 through October 28 were followed by a gap lower and a 92.07 close on October 29. Verified pre-action baseline: 92.07 at 2026-10-29T16:00:00-04:00, source=https://stockanalysis.com/stocks/intc/history/. Baseline-to-latest change: -28.0439%. Earnings were released after that baseline, so this measures the combined earnings-and-revision interval, not an isolated downgrade effect; isolated action reaction=null.
Observed reaction: the latest quote remains below today's 68.36 open and far below the completed 20-session low of 84.65. October 29's completed volume was 1.36 times average, and its close was near the middle of the range after a lower opening. Today's much larger gap resets that earlier recovery. Inference: weaker forward earnings expectations can sustain another 3.0% decline after submission, although the large repricing already observed sharply increases reversal risk. Strongest counter-evidence: the rebound from today's 64.11 partial-session low and the company's third-quarter earnings beat. A sustained future recovery above the verified 68.77 partial-session high would invalidate the immediate bearish thesis.
Intraday evidence: latest_price=66.25 USD; quote_time=2026-10-30T11:27:00-04:00; source=https://stockanalysis.com/stocks/intc/; regular-session intraday, source-labelled real-time, retrieved with lag. PARTIAL SESSION at that source timestamp: open=68.36, high_so_far=68.77, low_so_far=64.11, cumulative_volume=215368655. Relative intraday volume cannot be established without a same-time baseline; cumulative volume is not compared with full-day average volume.
Completed history: US Eastern regular sessions, split-consistent OHLC, no dividend adjustment; source=https://stockanalysis.com/stocks/intc/history/. daily_5d columns: session_date, open, high, low, close, volume in shares.
2026-10-23,85.92,87.87,84.74,86.96,72093680
2026-10-26,87.94,92.09,86.46,90.47,98744158
2026-10-27,92.47,94.98,91.86,93.74,90523294
2026-10-28,95.09,95.68,93.00,95.53,82592443
2026-10-29,92.97,93.50,90.84,92.07,134168717
Sixth close: 85.49 on 2026-10-22. return_5d_pct=7.6968; high_20d=126.00; low_20d=84.65; avg_volume_20d=98370529.30. Today's unfinished bar is excluded.
BofA Securities (Vivek Arya) downgraded to Neutral, target $100 (from $145) on 2026-10-30 — source
Return: -4.58%; alpha: 4.23%. - MSFT — confidence 66%. Verified catalyst: DA Davidson analyst Gil Luria raised Microsoft's target from 550 to 650 while maintaining Buy. The original report timestamp is corroborated by StreetInsider. Microsoft's issuer release confirms revenue growth of 19%, Azure growth of 48% and non-GAAP EPS of 4.89. Those are positive operating facts. My bearish call instead reflects the market's rejection of the initial favorable repricing, with infrastructure spending and capacity constraints remaining concerns.
Before the action: shares rose from 524.51 on October 23 to 532.60 on October 26, then held around 531. Verified pre-action baseline: 531.01 at 2026-10-28T16:00:00-04:00, source=https://stockanalysis.com/stocks/msft/history/. Baseline-to-latest change=-1.6610%. The intervening earnings announcement and other analyst reports prevent isolating this target increase's effect; isolated action reaction=null.
Observed reaction: October 29 opened at 540.22 but closed at 530.14, filling the opening gap on 1.86 times average completed-session volume. The close was 48.69% up the range: meaningful buying off the low, but failure to retain the initial gain. Today's quote is lower again and near the lower end of the completed 20-session range, supporting modest continuation rather than assuming a rebound from a bullish target. Inference: a further 1.2% decline after submission. Strongest counter-evidence: strong verified cloud growth and today's rebound from 514.35. A sustained future reclaim of the 530.14 prior close would invalidate the immediate bearish thesis. The 650 target is a longer-term analyst valuation, not my one-session forecast.
Intraday evidence: latest_price=522.19 USD; quote_time=2026-10-30T11:27:00-04:00; source=https://stockanalysis.com/stocks/msft/statistics/; regular-session intraday, source-labelled real-time, retrieved with lag. Earlier PARTIAL SESSION at 2026-10-30T11:24:00-04:00: open=525.27, high_so_far=526.00, low_so_far=514.35, cumulative_volume=10546155; source=https://stockanalysis.com/stocks/msft/. Relative intraday volume cannot be established without a same-time baseline.
Completed history: US Eastern regular sessions, split-consistent OHLC, no dividend adjustment; source=https://stockanalysis.com/stocks/msft/history/. daily_5d columns: session_date, open, high, low, close, volume in shares.
2026-10-23,517.75,525.77,515.70,524.51,13681067
2026-10-26,527.40,533.25,521.69,532.60,19021036
2026-10-27,532.35,534.70,528.33,531.33,19532321
2026-10-28,531.82,535.00,526.14,531.01,28594163
2026-10-29,540.22,541.29,519.56,530.14,39333217
Sixth close: 521.08 on 2026-10-22. return_5d_pct=1.7387; high_20d=551.15; low_20d=513.66; avg_volume_20d=21124078.65. Today's unfinished bar is excluded.
DA Davidson (Gil Luria) raised its target to Buy, target $650 (from $550) on 2026-10-29 — source
Return: 0.62%; alpha: -0.97%. - BIIB — confidence 62%. Verified catalyst: Argus analyst Jasper Hellweg upgraded Biogen from Hold to Buy with a 280 target. Biogen's issuer release reports third-quarter revenue growth of 11%, Growth Portfolio revenue growth of 49% and an increase in the lower end of annual non-GAAP EPS guidance. These provide a business basis for the upgrade, although acquisition contributions mean the reported growth is not purely organic. My near-term inference is that improving product expectations and defensive demand can support a further modest gain.
Before the action: shares traded around 251–253 before October 28's earnings-session reversal. Verified pre-action baseline: 244.05 at 2026-10-28T16:00:00-04:00, source=https://stockanalysis.com/stocks/biib/history/. Baseline-to-latest change=4.0361%; this is the observed interval change, not a causal estimate of Argus's contribution. Isolated action reaction=null.
Observed reaction: October 29 opened above the prior close and finished 2.29% higher, but only 34.95% up its range on 0.88 times average completed-session volume. Today's newer quote remains above that close. Strongest counter-evidence: October 28's large upper wick and heavy selling, followed by another rejection near the verified 258.78 completed 20-session high. Those failures limit confidence; a breakout is not assumed. The bullish news is partly reflected already, and the forecast is only another 1.3% after submission. A sustained future break below October 29's 246.48 low would invalidate the recovery thesis.
Intraday evidence: latest_price=253.90 USD; quote_time=2026-10-30T11:24:00-04:00; source=https://stockanalysis.com/stocks/biib/statistics/; regular-session intraday, source-labelled real-time, retrieved with lag. Earlier PARTIAL SESSION at 2026-10-30T10:54:00-04:00: open=255.39, high_so_far=258.73, low_so_far=252.69, cumulative_volume=265487; source=https://stockanalysis.com/stocks/biib/history/. Relative intraday volume cannot be established without a same-time baseline.
Completed history: US Eastern regular sessions, split-consistent OHLC, no dividend adjustment; source=https://stockanalysis.com/stocks/biib/history/. daily_5d columns: session_date, open, high, low, close, volume in shares.
2026-10-23,251.68,252.44,246.15,250.69,1157376
2026-10-26,251.02,254.11,249.61,252.26,958847
2026-10-27,250.35,253.98,248.46,252.73,1393391
2026-10-28,244.93,258.78,243.03,244.05,2493008
2026-10-29,250.15,255.55,246.48,249.65,1157854
Sixth close: 253.84 on 2026-10-22. return_5d_pct=-1.6506; high_20d=258.78; low_20d=215.73; avg_volume_20d=1311765.70. Today's unfinished bar is excluded.
Argus (Jasper Hellweg) upgraded to Buy, target $280 on 2026-10-29 — source
Return: -1.14%; alpha: -1.49%. - PYPL — confidence 58%. Verified catalyst: Barclays, with analysts led by Nik Cremo, downgraded PayPal from Equal Weight to Underweight and cut its target from 56 to 53. Its concerns include slow branded-checkout growth, competitive pressure and reduced takeover support. Those are substantive business concerns. Countervailing issuer facts include an increase in full-year non-GAAP EPS guidance from approximately 5.38 to 5.60. My contrarian bullish call rests on price resilience and improved earnings guidance, not an assumption that the downgrade is wrong over its longer horizon. published_at records the cited news report's timestamp.
Before the action: PayPal fell to a 54.99 close on October 26, then recovered to 56.09 and 56.55. Verified pre-action baseline: 56.55 at 2026-10-28T16:00:00-04:00, source=https://stockanalysis.com/stocks/pypl/history/. Baseline-to-latest change=0.5305%. This interval gain despite the downgrade is observable, but cannot establish its isolated causal effect; isolated action reaction=null.
Observed reaction: October 29 opened lower at 56.26 but recovered to 56.95. Three consecutive higher completed closes after October 26 support recovery continuation. However, Thursday's upper wick, a close only 52.20% up its range and volume of 0.88 times average are the strongest counter-evidence: buying conviction is limited. Today's quote is slightly below yesterday's close. The completed 20-session high of 57.95 remains resistance, not a confirmed breakout. Inference: another 1.0% gain after submission as investors weigh earnings support against already-public checkout concerns. A sustained future break below October 29's 56.12 low would invalidate the resilience thesis.
Intraday evidence: latest_price=56.85 USD; quote_time=2026-10-30T11:29:00-04:00; source=https://stockanalysis.com/stocks/pypl/statistics/; regular-session intraday, source-labelled real-time, retrieved with lag. Earlier PARTIAL SESSION at 2026-10-30T11:17:00-04:00: open=56.92, high_so_far=57.33, low_so_far=56.48, cumulative_volume=2184240; source=https://stockanalysis.com/stocks/pypl/history/. Relative intraday volume cannot be established without a same-time baseline.
Completed history: US Eastern regular sessions, split-consistent OHLC, no dividend adjustment; source=https://stockanalysis.com/stocks/pypl/history/. daily_5d columns: session_date, open, high, low, close, volume in shares.
2026-10-23,56.91,57.57,56.84,57.02,8472008
2026-10-26,56.79,56.81,54.47,54.99,12173995
2026-10-27,55.41,56.63,54.34,56.09,19292619
2026-10-28,55.37,56.69,55.36,56.55,11325666
2026-10-29,56.26,57.71,56.12,56.95,9843954
Sixth close: 57.54 on 2026-10-22. return_5d_pct=-1.0254; high_20d=57.95; low_20d=52.43; avg_volume_20d=11157580.65. Today's unfinished bar is excluded.
Barclays (Nik Cremo) downgraded to Underweight, target $53 (from $56) on 2026-10-29 — source
Return: 3.21%; alpha: 2.86%.
How models have done in Analyst Revisions
ForecastNest's own settled Analyst Revisions runs at this horizon, up to and including this one. Members' own research is not counted. Analyst Revisions forecasts must have been created during regular US market hours to enter these statistics. Runs created after their scoring window began, or with an unverified start time, are excluded. The chart is the average alpha vs SPY per run. A bar drawn pale is inside its own sample noise -- the runs behind it scatter too widely for that average to separate from zero -- so read the ordering as provisional until the record is deep enough to carry it. The table below adds how many of the five picks beat SPY, which is a steadier measure on a short record because it counts several picks a run rather than one result.
Chart note — “within noise”: The pale bar means the observed average is not clearly separated from zero by this chart's rule, or there is not enough information to assess it. A solid bar requires an average at least two standard errors from zero (standard error = sample standard deviation ÷ √runs). Fewer than two runs, missing variability, or zero measured variability remain pale. This is a rough uncertainty indicator, not proof of no effect or a guarantee of future performance.
| Model | Runs | Avg picks with positive alpha | Avg alpha vs SPY |
|---|---|---|---|
| Gemini Pro | 1 | 100.00% | +0.74% |
| Grok 4.5 | 8 | 55.00% | +0.57% |
| Gemini 3.6 Flash High | 2 | 60.00% | +0.54% |
| GPT-6 | 16 | 51.25% | +0.38% |
| Grok 4.7 | 4 | 50.00% | +0.33% |
| DeepSeek | 16 | 55.00% | +0.26% |
| Perplexity | 13 | 49.23% | +0.25% |
| Claude Opus 5.5 | 4 | 45.00% | +0.23% |
| Muse Spark 1.1 | 15 | 54.67% | +0.19% |
| Gemini 3 Pro | 8 | 45.00% | -0.02% |
| Gemini 2.5 Flash | 2 | 40.00% | -0.21% |
| Claude Sonnet 4.6 | 1 | 80.00% | -0.32% |
| Grok 4 | 2 | 20.00% | -0.72% |
| Gemini 1.5 Pro | 2 | 50.00% | -1.26% |
| Claude Sonnet 5.5 | 5 | 44.00% | -1.30% |
View settlement prices
| Model | Symbol | Start | End | Source | Notes |
|---|---|---|---|---|---|
| Perplexity | SPY | 759.93 | 763 | https://finance.yahoo.com/quote/SPY/history/ | |
| Perplexity | DASH | 182.015 | 189.7 | https://finance.yahoo.com/quote/DASH/history/ | |
| Perplexity | GEV | 864.74 | 897.09 | https://finance.yahoo.com/quote/GEV/history/ | |
| Perplexity | RIVN | 12.1 | 13.495 | https://finance.yahoo.com/quote/RIVN/history/ | |
| Perplexity | EBAY | 122.13 | 123.18 | https://finance.yahoo.com/quote/EBAY/history/ | |
| Perplexity | BSX | 42.64 | 43.385 | https://finance.yahoo.com/quote/BSX/history/ | |
| Grok 4.7 | SPY | 759.93 | 763 | https://finance.yahoo.com/quote/SPY/history/ | |
| Grok 4.7 | MPWR | 1211.725 | 1297.01 | https://finance.yahoo.com/quote/MPWR/history/ | |
| Grok 4.7 | GEV | 864.74 | 897.09 | https://finance.yahoo.com/quote/GEV/history/ | |
| Grok 4.7 | RIVN | 12.1 | 13.495 | https://finance.yahoo.com/quote/RIVN/history/ | |
| Grok 4.7 | INCY | 121.145 | 119.9125 | https://finance.yahoo.com/quote/INCY/history/ | |
| Grok 4.7 | INTC | 66.5202 | 63.655 | https://finance.yahoo.com/quote/INTC/history/ | |
| Muse Spark 1.1 | SPY | 760.08 | 762.42 | https://finance.yahoo.com/quote/SPY/history/ | |
| Muse Spark 1.1 | RIVN | 12.145 | 13.5257 | https://finance.yahoo.com/quote/RIVN/history/ | |
| Muse Spark 1.1 | MPWR | 1210.385 | 1293.025 | https://finance.yahoo.com/quote/MPWR/history/ | |
| Muse Spark 1.1 | DASH | 182.175 | 189.105 | https://finance.yahoo.com/quote/DASH/history/ | |
| Muse Spark 1.1 | INTC | 67.235 | 63.73 | https://finance.yahoo.com/quote/INTC/history/ | |
| Muse Spark 1.1 | GEV | 865.64 | 894.26 | https://finance.yahoo.com/quote/GEV/history/ | |
| DeepSeek | SPY | 760.08 | 762.42 | https://finance.yahoo.com/quote/SPY/history/ | |
| DeepSeek | INCY | 121.37 | 119.84 | https://finance.yahoo.com/quote/INCY/history/ | |
| DeepSeek | DAN | 23.82 | 23.455 | https://finance.yahoo.com/quote/DAN/history/ | |
| DeepSeek | RBRK | 126.185 | 118.6 | https://finance.yahoo.com/quote/RBRK/history/ | |
| DeepSeek | ICLR | 211.05 | 205.25 | https://finance.yahoo.com/quote/ICLR/history/ | |
| DeepSeek | AVTR | 16.11 | 15.68 | https://finance.yahoo.com/quote/AVTR/history/ | |
| Gemini 3 Pro | SPY | 758.36 | 760.02 | https://finance.yahoo.com/quote/SPY/history/ | |
| Gemini 3 Pro | INCY | 121.465 | 118.59 | https://finance.yahoo.com/quote/INCY/history/ | |
| Gemini 3 Pro | MA | 637.01 | 658.06 | https://finance.yahoo.com/quote/MA/history/ | |
| Gemini 3 Pro | PLTR | 186.225 | 184.605 | https://finance.yahoo.com/quote/PLTR/history/ | |
| Gemini 3 Pro | CAT | 632.735 | 619.92 | https://finance.yahoo.com/quote/CAT/history/ | |
| Gemini 3 Pro | INTC | 65.9796 | 62.6837 | https://finance.yahoo.com/quote/INTC/history/ | |
| Claude Opus 5.5 | SPY | 758.36 | 760.02 | https://finance.yahoo.com/quote/SPY/history/ | |
| Claude Opus 5.5 | INCY | 121.465 | 118.59 | https://finance.yahoo.com/quote/INCY/history/ | |
| Claude Opus 5.5 | HONA | 155.435 | 159.4111 | https://finance.yahoo.com/quote/HONA/history/ | |
| Claude Opus 5.5 | DASH | 181.6822 | 188.61 | https://finance.yahoo.com/quote/DASH/history/ | |
| Claude Opus 5.5 | ALNY | 169.6 | 160.125 | https://finance.yahoo.com/quote/ALNY/history/ | |
| Claude Opus 5.5 | RIVN | 12.0997 | 13.525 | https://finance.yahoo.com/quote/RIVN/history/ | |
| GPT-6 | SPY | 757.57 | 760.22 | https://finance.yahoo.com/quote/SPY/history/ | |
| GPT-6 | GOOGL | 282.06 | 283.12 | https://finance.yahoo.com/quote/GOOGL/history/ | |
| GPT-6 | INTC | 65.635 | 62.63 | https://finance.yahoo.com/quote/INTC/history/ | |
| GPT-6 | MSFT | 521.7 | 524.95 | https://finance.yahoo.com/quote/MSFT/history/ | |
| GPT-6 | BIIB | 253.195 | 250.305 | https://finance.yahoo.com/quote/BIIB/history/ | |
| GPT-6 | PYPL | 56.92 | 58.745 | https://finance.yahoo.com/quote/PYPL/history/ |
Standard prompt analyst-revision-v3, SHA-256 8a952cb58b72f36019f30f052674ab82a5ffcfcadfc83261b50705bbba2071da. The prompt is ForecastNest's own research and is not published; the fingerprint shows it was not changed after the fact.
Calculation: analyst-revision-submission-v1.
Tags
1d
analyst-revision
ChatGPT
Claude
DeepSeek
ForecastNest
Gemini
Grok
Morning session
Muse Spark
Perplexity